Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05759247Not ApplicableActive Not Recruiting

Evaluation of the Use of a Remote Monitoring and Follow-up Option for Patients With Chronic Obstructive Pulmonary Disease (BOREAL)

Role: collaborator

NCT06523140Not ApplicableRecruiting

Management of COPD Patients With BoraCare® Remote Monitoring Solution Including BVS3 Early Detection Score for COPD Exacerbations

Role: lead

NCT06445686Recruiting

Ongoing Monitoring of Vital Signs in Patients With Idiopathic Pulmonary Fibrosis Before and After Acute Exacerbation.

Role: lead

NCT04034901Not ApplicableCompleted

Study of Physiological Signals During and After COPD Exacerbations

Role: lead

NCT04064645Not ApplicableCompleted

Bora Band Respiration Rate Study

Role: lead

NCT03918018Not ApplicableCompleted

BiOSENCY BORA Band SpO2 Validation Study

Role: lead

All 6 trials loaded